Delivery Order SPE2DB22D3004-SPE2DB25FQ94A
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on April 21, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Methylphenidate ER(LA) 30mg capsules in a quantity of 100 units. The contract carries a firm fixed price ceiling value of $1,374.60 and is scheduled for completion by April 22, 2025. This is a competitively awarded, non-set-aside delivery order with no small business...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,301.28 for Methylphenidate ER(LA) 10mg capsules (100-count) on September 23, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,827.84. This is a firm fixed-price contract with an ultimate completion date of September 19, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement issued under DLA's...
- This is a delivery order issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,163.58, is for the supply of 4567142003 - Methylphenidate LA 40 mg capsules. The contract is a Firm Fixed Price delivery order with a period of performance through February 4, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,098.70 Firm Fixed Price delivery order is for the supply of 4,565,744,291 tablets of Methylphenidate ER 36 mg. The contract has an ultimate completion date of September 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,557,327 units of Methylphenidate ER (long-acting) 10mg capsules, with a total ceiling value of $1,188.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,897.25 contract is for the delivery of 4,563,527,230 units of methylphenidate LA 20 mg capsules over the period ending February 5, 2024. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,682.51 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,566,177,514 units of Methylphenidate ER 27 mg tablets. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count units) with a ceiling value of $1,533.28. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date is...
- This federal contract award is for the delivery of Methylphenidate ER 18 mg tablets to the Defense Logistics Agency (DLA). The $1,768.34 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has an ultimate completion date of October 15, 2024 and does not utilize a set-aside designation. As a large indefinite delivery vehicle (IDV) contractor with the DLA Troop Support Medical, valued up to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ94ADelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, with a firm fixed price ceiling value of $1,096.70. The award covers the supply of Methylphenidate ER(LA) 40mg capsules in a quantity of 100 units, with an ultimate completion date of September 29, 2025. This is a non-set-aside competitive award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates its critical role as a pharmaceutical supplier to military and veteran healthcare systems. The delivery order represents a routine transaction within the broader scope of the SPE2DX IDC, which authorizes the company to supply a wide range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. The company's track record of competitively awarded contracts with firm fixed pricing reflects its capability to meet federal medical procurement standards across therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/26/25 |